These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34993073)

  • 1. Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients.
    Tan Y; Duan T; Li B; Zhang B; Zhu Y; Yan K; Song J; Lv T; Yang J; Jiang L; Yang J; Wen T; Yan L
    Quant Imaging Med Surg; 2022 Jan; 12(1):215-228. PubMed ID: 34993073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma.
    Wu MY; Yeh CH; Liao CC; Chen CL; Wang CC; Lin CC; Chang WC; Cheng YF; Ou HY
    Transplant Proc; 2024 Apr; 56(3):573-580. PubMed ID: 38326205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Tumor Necrosis Factor-α Is Inversely Associated With the Psoas Muscle Index in Both Male and Female Patients Scheduled for Living Donor Liver Transplantation.
    Shim JW; Yang S; Jung JY; Choi HJ; Chung HS; Hong SH; Park CS; Choi JH; Chae MS
    Transplant Proc; 2019; 51(6):1874-1879. PubMed ID: 31262437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients.
    Wu MY; Lim WX; Cheng YF; Chang CD; Hsu HW; Lin CC; Chen CL; Chang WC; Yu CY; Tsang LL; Chuang YH; Ou HY
    Sci Rep; 2021 Sep; 11(1):19247. PubMed ID: 34584142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant.
    Tsao YT; Lee WC; Huang CH; Lin IH; Huang YY
    J Formos Med Assoc; 2022 Jul; 121(7):1317-1324. PubMed ID: 34666924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Fujimoto Y; Ogawa K; Mori A; Hammad A; Tamai Y; Inagaki N; Uemoto S
    Liver Transpl; 2014 Nov; 20(11):1413-9. PubMed ID: 25088484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Hammad A; Tamai Y; Inagaki N; Uemoto S
    Nutrition; 2016; 32(11-12):1200-5. PubMed ID: 27292773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia is a prognostic factor in living donor liver transplantation.
    Masuda T; Shirabe K; Ikegami T; Harimoto N; Yoshizumi T; Soejima Y; Uchiyama H; Ikeda T; Baba H; Maehara Y
    Liver Transpl; 2014 Apr; 20(4):401-7. PubMed ID: 24357065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease.
    Manabe T; Ogawa C; Takuma K; Nakahara M; Oura K; Tadokoro T; Fujita K; Tani J; Shibatoge M; Morishita A; Kudo M; Masaki T
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal CT study of sarcopenia due to hepatic failure after living donor liver transplantation.
    Onuma T; Kamishima T; Shimamura T; Kawamura N; Yamashita K; Sutherland K; Takeda H
    Quant Imaging Med Surg; 2018 Feb; 8(1):25-31. PubMed ID: 29541620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation.
    Shirai H; Kaido T; Hamaguchi Y; Yao S; Kobayashi A; Okumura S; Kamo N; Yagi S; Okajima H; Uemoto S
    Nutrition; 2018 Jan; 45():1-10. PubMed ID: 29129228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival.
    Chan KM; Cheng CH; Wu TH; Lee CF; Wu TJ; Chou HS; Lee WC
    Cancer Manag Res; 2019; 11():7295-7305. PubMed ID: 31447587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
    Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.